Revance Therapeutics has an Implied Volatility (IV) of 68.2% p.a. for a constant maturity of 30 days. The
Implied Volatility Rank (IVR) for RVNC is
12 and the
Implied Volatility Percentile (IVP) is
24. The current Implied Volatility Index for RVNC is -0.7 standard deviations away from its 1 year mean of 88.3%.
Data as of 6/8/2023